Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
05/2013
05/09/2013US20130115221 HIFa prolyl hydroxylation assay
05/08/2013EP2589601A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof
05/08/2013EP2589592A1 Novel nicotinamide derivatives or salts thereof
05/08/2013EP2589383A1 FKBP subtype-specific rapamycin analogue for use in treatment of diseases
05/08/2013EP2588499A1 Antibodies that are capable of specifically binding tissue factor pathway inhibitor
05/08/2013EP2588196A2 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
05/08/2013EP2502939A9 Nonnatural collagen-like protein and use thereof
05/08/2013CN103097392A Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
05/08/2013CN103096903A The therapeutic use of tetrathiomolybdate
05/08/2013CN103091445A Quality detection method of Eleutherine plicata Herb and extract thereof
05/08/2013CN103087889A Aphrodisiac wine and preparation method thereof
05/08/2013CN103087153A New neovessel inhibition small peptides and applications thereof
05/08/2013CN103087078A Thienopyridine and furopyridine kinase inhibitors
05/08/2013CN103086980A Pyrimidine compound for efficiently promoting stem cell proliferation and use thereof
05/08/2013CN103086862A Hydroxydecyl quinone derivative for treating or preventing nerve diseases
05/08/2013CN103086861A Hydroxydecyl benzoquinone derivative and application thereof
05/08/2013CN103083677A Permeation accelerator and application thereof to permeation acceleration
05/08/2013CN103083614A Medicine formula for treating chronic aplastic anemia
05/08/2013CN103083570A Traditional Chinese medicine for treating anaphylactoid purpura
05/08/2013CN103083562A Preparation method for traditional Chinese medicine prescription capable of treating thalassemia
05/08/2013CN103083541A Drug for treating anemia
05/08/2013CN103083512A Traditional Chinese medicine for treating anemia
05/08/2013CN103083477A Anti-tumor dripping pills
05/08/2013CN103083458A Warm light drink compound formula granule, as well as preparation method as well as detection method thereof
05/08/2013CN103083449A Stop-bleeding medicine and preparation method thereof
05/08/2013CN103083442A Preparation method for newborn hemolytic disease treatment traditional Chinese medicine preparation
05/08/2013CN103083440A Multi-functional natural healthcare product
05/08/2013CN103083435A Diuretic formula
05/08/2013CN103083380A Pill for treating leukopenia and making method
05/08/2013CN103083353A Antimicrobial Locking Solutions Comprising Taurinamide Derivatives And Biologically Acceptable Salts And Acids, With The Addition Of Small Concentrations Of Heparin
05/08/2013CN103083306A Application of salvianolic acid A composition in preparing medicines for inhibiting brain tissue neuron damage or death
05/08/2013CN103083305A Salvianolic acid A composition and application thereof in preparing medicines
05/08/2013CN103083304A Application of salvianolic acid A composition for preparing medicines for preventing and/or treating cerebral thrombosis
05/08/2013CN103083303A Application of salvianolic acid A composition in preparing medicines for improving neural function symptom after cerebral ischemia
05/08/2013CN103083302A Application of salvianolic acid A composition in preparing medicines for protecting ischemic brain tissue damage
05/08/2013CN103083301A Application of salvianolic acid A composition for preparing medicines for preventing and/or treating cerebral thrombosis
05/08/2013CN103083300A Application of salvianolic acid A composition in preparing medicines for protecting cerebrovascular endothelial cells
05/08/2013CN103083299A Salvianolic acid A composition and application thereof in preparing medicines
05/08/2013CN103083298A Application of salvianolic acid A composition in preparing medicines for protecting ischemic brain tissue damage
05/08/2013CN103083297A Application of salvianolic acid A composition in preparing medicines for improving neural function symptom after cerebral ischemia
05/08/2013CN103083296A Application of salvianolic acid A composition in preparing medicines for protecting cerebrovascular endothelial cells
05/08/2013CN103083295A Application of salvianolic acid A freeze-dried powder injection in preparing medicines for improving neural function symptom after cerebral ischemia
05/08/2013CN103083294A Application of salvianolic acid A freeze-dried powder injection in preparing medicines for protecting ischemic brain tissue damage
05/08/2013CN103083279A Polysaccharide sulfate soft capsule
05/08/2013CN103083268A Polysaccharide sulfate dispersible tablet
05/08/2013CN103083267A Polysaccharide sulfate chewable tablet
05/08/2013CN103083261A Polysaccharide sulfate freeze-dried powder injection
05/08/2013CN103083257A Salvianolic acid A freeze-dried powder injection and application thereof for preparing medicines
05/08/2013CN103083256A Application of salvianolic acid A freeze-dried powder injection for preparing medicines for preventing and/or treating cerebral thrombosis
05/08/2013CN103083254A Application of salvianolic acid A freeze-dried powder injection for preparing medicines for preventing and/or treating cerebral thrombosis
05/08/2013CN103083248A Polysaccharide sulfate dry suspension
05/08/2013CN103083224A Method for preparing dexamethasone slow-release medicine carrier
05/08/2013CN103082296A Dietary supplement for reducing attacking of myocardial infarction
05/08/2013CN102512593B Traditional Chinese medicine preparation for treating aplastic anemia
05/08/2013CN102060842B 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition
05/08/2013CN101862349B Effective part of centipede and application thereof
05/08/2013CN101641368B Method for producing soluble thrombomodulin of high purity
05/07/2013US8435981 2-(heterocyclylbenzyl)pyridazinone derivatives
05/07/2013US8435779 Process for producing a virus-inactivated thrombin preparation
05/07/2013CA2659664C Improved radiation therapy methods
05/07/2013CA2558029C Ion binding polymers and uses thereof
05/07/2013CA2514100C Carboxamide derivatives and the use thereof as factor xa inhibitors
05/07/2013CA2491131C Novel compounds as histone deacetylase inhibitors
05/07/2013CA2459562C Synthetic heparin pentasaccharides
05/02/2013WO2013062305A1 Method for preparing highly concentrated fibrinogen solution and method for preparing fibrin sealant by using thereof
05/02/2013WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative
05/02/2013WO2013060303A1 Polypeptides inhibiting neovascularization and uses thereof
05/02/2013WO2013060098A1 Kinase inhibitor and method for treatment of related diseases
05/02/2013WO2013060052A1 Hypoallergenic recombinant immunotoxin, and preparation method and application thereof
05/02/2013WO2013036902A4 Submicron particles to decrease transfusion
05/02/2013US20130110066 Foam and Delivery System for Treatment of Postpartum Hemorrhage
05/02/2013US20130109702 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
05/02/2013US20130109623 G-csf and water-soluble polymer conjugate
05/02/2013US20130109614 Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins
05/02/2013US20130108694 Dry blend formulation of tetrahydrobiopterin
05/02/2013US20130108650 Actriib binding agents and uses thereof
05/02/2013CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative
05/02/2013CA2853440A1 Kinase inhibitor and method for treatment of related diseases
05/02/2013CA2852019A1 Method for preparing highly concentrated fibrinogen solution and method for preparing fibrin sealant by using thereof
05/01/2013EP2586464A1 Tolvaptan solid dispersion and its preparation method
05/01/2013EP2586439A1 Combination therapy with a compound acting as a platelet ADP receptor inhibitor
05/01/2013EP2585093A2 Compositions and methods for treatment of thrombosis and prolonging survival of stored platelets
05/01/2013EP2585082A2 One step removal of selected molecules from body fluid and tissue
05/01/2013EP2585080A1 Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings
05/01/2013EP2585079A1 Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery
05/01/2013EP2585078A1 Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopaedic surgery
05/01/2013EP2585055A1 Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes
05/01/2013CN103080135A Antibodies that are capable of specifically binding tissue factor pathway inhibitor
05/01/2013CN103080104A N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
05/01/2013CN103079644A Anti-TIM-3 antibody
05/01/2013CN103079565A Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
05/01/2013CN103073650A Red stilbene polysaccharide 4 and effective component preparation and application
05/01/2013CN103073631A Hemopoietin analogue
05/01/2013CN103073508A Kinase inhibitor and method for treating related diseases
05/01/2013CN103071154A Combination anticoagulant therapy with a compound that acts as a factor XA inhibitor
05/01/2013CN103071136A Traditional Chinese medicine health care product capable of regulating yin and yang balance of human bodies and preparation method of traditional Chinese medicine health care product
05/01/2013CN103071122A Jiashu swelling eliminating powder
05/01/2013CN103071081A Pharmaceutical composition for curing edema and preparation method thereof
05/01/2013CN103071046A Medicine paste for treating high myopia macular hemorrhage
05/01/2013CN103071041A Chinese medicinal preparation for treating anemia and preparation method
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 671